The US pension risk transfer market has had, to put it mildly, a sluggish first half of the year, at least in terms of annual premium. Just $4bn of buy-in and buy-out sales in Q1 were followed by only $3bn in Q2, declines of 47% and 27%, respectively.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Related Posts
Global Equity Release Market Participants Remain Bullish Despite Macro Headwinds
The global equity release market could triple in size to $52bn by 2035, according to…
Litigation Update: Estate of Long v. Wells Fargo Bank, N.A.
A recent Memorandum Opinion issued by the Superior Court of the State of Delaware (Complex…
Q&A: Alexandr Dudarev, CEO, Inshurik
Alexandr Dudarev, CEO of Inshurik, an AI-driven insurance platform, offers his thoughts on a range…
New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance
Regulation changes to impact pension risk transfer market on both sides of the Atlantic.